Zacks upgraded San Diego-based Cytori Therapeutics to a "buy" rating from a "hold" rating on Feb. 9, according to InterCooler.
Spinal Tech
Amedica is now in compliance with NASDAQ listing requirements after a period last year where the company's share price dipped below $1.
Ellipse Technologies withdrew its initial public offering yesterday, according to a Renaissance Capital report.
At the Arab Health Exhibition and Congress in Dubai, Medtronic launched its Valleylab FT10 energy platform, according to Trade Arabia.
Oppenheimer analysts reaffirmed Zimmer Biomet's "outperform" rating, according to Wallstreet.org.
Advertisement
Rick Pospisil, MD, of Huntington Beach (Calif.), is offering patients procedures to treat carpal tunnel syndrome.
OrthAlign has entered into a multi-country distribution agreement with Smith & Nephew.
NuVasive reached a new 52-week low on Feb. 8, according to Equities.com.
Implanet hired Brian T. Ennis as president of Implanet America.
David Greenwald, MD, successfully implanted the 1st patent-pending VerteLP Lateral Lumber Cage from VGI Medical.